NAGS and lung adenocarcinoma: Histone modifications, CTCF, and RNA polymerase II binding to NAGS, CPS1, and citrin regulatory regions in the liver, lung, and A549 lung adenocarcinoma cells suggest that all three genes appear to be poised for expression in the lung tissue.